This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The adoption of pharmacists in general practice has resulted in improvements in prescribing quality, according to a recent study. Theresearch, by the University of Manchester, looked at the differences in prescribing indicators in general practices with and without pharmacists between September 2015 and December 2019. During this period, the proportion of practices employing a pharmacist […] The post Pharmacists in general practice improve prescribing quality, study finds appeared first on
As veterinarians, flu scientists, and biosecurity experts, we have watched with growing concern the rise in H5N1 avian influenza in cats. Since 2022, more than 100 domesticated cats in the United States have had confirmed infections — some house pets, some barn cats, some feral — with high mortality, although mortality data remain undocumented on federal sites.
Avoiding Patent Pitfalls in Biopharmaceutical Development: A Freedom to Operate Analysis As a biopharmaceutical professional, you know how crucial it is to navigate the complex landscape of patents and intellectual property. One of the most critical steps in this process is conducting a freedom to operate (FTO) analysis. But what does this entail, and how can you ensure efficient and robust results?
The Indian pharmaceutical industry is evolving rapidly, leading to the emergence of new leadership roles that address the sector’s dynamic global challenges and opportunities. As the sector adapts to technological advancements, regulatory requirements, and increasing competition, several leadership role trends are emerging. These roles are designed to strengthen the companies’ operational efficiency, expand their market presence, and foster innovation.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Panelists discuss how pharmacists employ multiple strategies to support medication adherence in older adults with TD, including simplifying dosing regimens, utilizing medication synchronization programs, providing medication packaging solutions, conducting regular follow-up calls, and collaborating closely with prescribers and care teams to develop and adjust personalized treatment plans that address individual patient needs and barriers to care.
Recently, the notorious conspiracy theory peddler Alex Jones shared an “Infowars” video on X lambasting the “horrific side effects” of Covid vaccines: “Yale scientists link COVID vaccines to alarming new syndrome causing distinct biological changes to the body,” his post read. News of the new study spread like wildfire throughout right-wing anti-vaccine circles, amplified by the likes of Alex Berenson , Elon Musk , and Joe Rogan , who touted the study as
The Secret Language of Medicines: Uncovering the Science Behind Pharmaceutical Drug Names As professionals in the healthcare and pharmaceutical industries, we've all seen them - the long, complex names of medications that seem to defy pronunciation. But have you ever stopped to think about the process behind creating these names? It's a fascinating world of science and art that's crucial to ensuring patient safety and efficacy.
The Secret Language of Medicines: Uncovering the Science Behind Pharmaceutical Drug Names As professionals in the healthcare and pharmaceutical industries, we've all seen them - the long, complex names of medications that seem to defy pronunciation. But have you ever stopped to think about the process behind creating these names? It's a fascinating world of science and art that's crucial to ensuring patient safety and efficacy.
Biocon Biologics announced the successful results of a pivotal Phase 3, randomised, double-blind, parallel group, multicenter study comparing Yesintek (Biocon Biologics biosimilar to Ustekinumab, called YESINTEK) with reference product Stelara (Ustekinumab) in adult patients with moderate to severe chronic plaque psoriasis (PsO). The data are being presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida.
A team of researchers in Japan have developed a novel artificial photosynthesis method that transforms waste organic compounds into valuable pharmaceuticals and energy using sunlight and water. The approach, known as artificial photosynthesis directed toward organic synthesis (APOS), represents a major step forward in sustainable chemical manufacturing.
Jazz Pharmaceuticals said Wednesday it would spend nearly $1 billion to buy Chimerix and its experimental pill for a devastating brain tumor that primarily affects children and young adults. The tumor, known as diffuse midline glioma, or DMG (and sometimes as DIPG depending on where it’s found), has flummoxed researchers for decades. It often wraps itself around a patient’s brain stem, preventing surgeons from safely excising it.
The Future of Diabetes Care: How Biosimilar Insulin Products Are Revolutionizing Treatment As we continue to navigate the ever-evolving landscape of diabetes care, one thing is clear: innovation is key. And when it comes to insulin therapy, a game-changing trend is emerging: biosimilar insulin products. For those who may be unfamiliar, biosimilars are highly similar versions of existing biologic medications, including insulin.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The European Union’s medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen’s Alzheimer’s drug, Leqembi, after concluding a safety review. The European Medicines Agency (EMA) in late January said the European Commission had requested a review of additional safety information for the drug, following its November approval to treat some patients with early Alzheimer’s disease.
Introduction In the highly regulated world of pharmaceutical marketing , mastering Google Ads management can be a game-changer. With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. However, the landscape isnt simple.
In early January, I received a letter in the mail from the Wisconsin Department of Health Services. The letter informed me that I had been approved for Medicaid-funded Home and Community-Based Services (HCBS), a form of long-term care. It had been five months since I’d applied to the program, after being discharged from the hospital in August 2024 as a new full-time wheelchair user.
The Unseen Heroes of Generic Drug Development: Pharmacovigilance As a generic drug developer, you're no stranger to the challenges of bringing affordable medications to market. From navigating complex regulatory landscapes to ensuring the quality and safety of your products, every step of the process requires meticulous attention to detail. But have you ever stopped to think about the unsung heroes of generic drug development?
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Union Minister of Chemicals and Fertilizers, and Health and Family Welfare, Jagat Prakash Nadda inaugurated the weeklong celebrations of Jan Aushadhi Diwas, 2025 by flagging off the Rath (Chariot) and 10 other vehicles carrying the information about Pradhan Mantri Bhartiya Janaushadhi Pariyojana from Nirman Bhawan. Union Minister of State for Chemicals and Fertilisers, Anupriya Patel and Secretary, Department of Pharmaceuticals, Amit Agrawal were also present on the occasion.
Introduction Pharmaceutical marketing has changed. Traditional outreach methods are no longer enough to engage healthcare professionals (HCPs) and patients in a digital-first world. Thats where PPC advertising strategies come into play. But heres the challenge pharma PPC isnt like other industries. Regulatory restrictions, compliance concerns, and complex audience targeting make it one of the toughest sectors to master in digital advertising.
The Food and Drug Administration scolded a company for a promotional display that falsely claimed its brand-name medicine was more effective than generic versions, which is apparently the first time the agency office responsible for monitoring advertising has cited such an issue. In a Feb. 3 letter posted on the FDA website this week, the Office of Prescription Drug Promotion wrote that Edenbridge Pharmaceuticals displayed a panel about its Hemady treatment for multiple myeloma in a conference e
Unlock the Power of Google Patents for Drug Patent Research As a researcher or professional in the pharmaceutical industry, staying on top of the latest developments in drug patents is crucial for making informed decisions. But with the vast amount of information available, it can be overwhelming to know where to start. That's where Google Patents comes in a powerful tool that can help you streamline your research and uncover valuable insights.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Funding in the pharma and healthcare space plummeted 85.83 per cent to $ 42.5 million in February 2025 from $ 300 million in January 2025. This is also a 78.86 per cent plunge in funding when compared with the $201 million raised in February 2024. The decline in investment activity makes February 2025 one of the lowest-funded months in the past 12 months in the sector.
The oral Factor B inhibitor of the alternative complement pathway is designed for this rare kidney condition with no approved treatments, which significantly impacts young individuals’ lives. The CHMP’s positive opinion is grounded in the outcomes from the Phase III trial, APPEAR-C3G. Fabhalta demonstrated a 35.1% decrease in proteinuria at six months against a placebo.
Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers compete for market share and try to draw patients away from compounding pharmacies that have been making cheaper copies of weight loss drugs. Wegovy normally carries a list price of about $1,350 a month, but Novo will sell the treatment through its new direct-to-consumer offering called NovoCare Pharmacy at $499 a month for all doses to ca
Almost 120,000 packs of Boots Paracetamol have been recalled because of a packaging error where they are incorrectly labelled as Aspirin on the foil blister. The Medicines and Healthcare products Regulatory Agency (MHRA) has today issued a recall alert for a specific batch of Boots Paracetamol 500mg (16s) and has advised the public to stop […] The post Boots Paracetamol batch recalled after being wrongly labelled as Aspirin appeared first on The Pharmacist.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
On National Safety Day 2025, the Indian Drug Manufacturers Association (IDMA) launches IDMA CARES, a dedicated initiative to strengthen workplace safety, Prevention of Sexual Harassment (POSH), and Environmental, Social, and Governance (ESG) principles. Under the campaign CARE Creating an Accountable, Respectful, and Empowered Workplace, IDMA aims to address: Workplace safety Ensuring the well-being of employees and communities POSH compliance Creating safe, inclusive, and harassment-free wor
On March 5, 2025, the U.S. Court of Appeals for the Federal Circuit affirmed the District Court for the Northern District of West Virginias entry of a preliminary injunction preventing Celltrion, Inc. (Celltrion) from launching CT-P42, its aflibercept biosimilar of EYLEA. As we have previously reported , the Federal Circuit recently affirmed a similar preliminary injunction against Samsung and Formycon.
The obesity medicine field has gained a new entrant, with AbbVie on Monday announcing it had licensed an experimental weight loss drug from a Danish company that is in a Phase 1 trial. The deal includes a $350 million upfront payment to the company, Gubra, for the rights to its drug, called for now GUB014295. AbbVie will pay up to some $1.9 billion if certain development and sales milestones are met.
Some hormonal contraceptives are associated with a small but significant increased risk of stroke and heart attack, according to a large and detailed study from Denmark. The analysis was based on national prescription records for more than two million Danish women between 1996 and 2021. It showed that contemporary oestrogen-progestin and progestin-only contraceptives were associated […] The post Heart attack and stroke risk higher with certain hormonal contraceptives appeared first on The
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
This approval covers all indications of the reference products and the biosimilars are anticipated to be available by June 2025 in the country as per the settlement agreement with Amgen. The agencys decision is supported by clinical evidence, along with outcomes from Phase III trials in postmenopausal women with osteoporosis. The studies aimed to assess the pharmacodynamics, immunogenicity, pharmacokinetics, efficacy, and safety of CT-P41 compared to reference denosumab.
Breaking Down Barriers: The Power of Global Research Collaborations in Generic Drug Development As the world grapples with the complexities of healthcare, one thing is clear: the need for innovative solutions has never been more pressing. In the realm of generic drug development, international research collaborations are emerging as a game-changer. By pooling resources, expertise, and knowledge, researchers from around the globe can accelerate the discovery of life-saving treatments and make the
The Department of Justice is investigating Semler Scientific for possible violations of a federal anti-fraud law related to its marketing of a product known as QuantaFlo, a test used in the diagnosis of peripheral artery disease by UnitedHealth Group and other large insurers. In a recent filing with the Securities and Exchange Commission, Semler disclosed that the government is investigating the use of QuantaFlo related to claims made for reimbursement from government health programs, which in s
Lawmakers on both sides of the aisle are renewing a multi-year effort to crack down on drug middlemen, known as pharmacy benefit managers (PBMs). These middlemen control what patients pay at the pharmacy counter, where they can get their medicine, what medicines they can get and what hoops they must jump through. The effort in Congress reflects mounting pressure to hold PBMs accountable and help lower patients’ out-of-pocket costs.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
71 
Let's personalize your content